XML 68 R53.htm IDEA: XBRL DOCUMENT v3.21.1
SHARE-BASED PAYMENTS - Schedule of Share-based Compensation, Restricted Stock, Restricted Stock Units Activity and SAR's (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 12 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Dec. 31, 2020
Restricted Stock Units (RSUs)      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Share-based Payment Arrangement, Expense $ 360 $ 410  
Number of Shares      
Granted, nonvested, number of shares (in shares) 440,000 740,000  
Restricted Stock Units (RSUs) | Equity Option      
Number of Shares      
Number of nonvested shares, beginning of period (in shares) 1,094,056    
Granted, nonvested, number of shares (in shares) 441,241    
Vested, number of shares (in shares) (635,233)    
Nonvested options forfeited, number of shares (in shares) 0    
Number of nonvested shares, end of period (in shares) 900,064   1,094,056
Weighted Average Grant Date Fair Value      
Nonvested, weighted average grant date fair value, beginning of period (in dollars per share) $ 1.98    
Granted, nonvested, weighted average grant date fair value (in dollars per share) 3.89    
Vested, weighted average grant date fair value (in dollars per share) 1.94    
Nonvested options forfeited, weighted average grant date fair value (in dollars per share) 0    
Nonvested, weighted average grant date fair value, end of period (in dollars per share) $ 2.94   $ 1.98
Stock Appreciation Rights (SARs)      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Share-based Payment Arrangement, Expense $ 140 $ 330  
Number of Shares      
Number of nonvested shares, beginning of period (in shares) 1,720,623 2,165,509 2,165,509
Granted, nonvested, number of shares (in shares) 0   0
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised 0   0
Nonvested options forfeited, number of shares (in shares) 0   (444,886)
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Expirations 0   0
Number of nonvested shares, end of period (in shares) 1,720,623   1,720,623
Weighted Average Grant Date Fair Value      
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Exercised, Weighted Average Exercise Price $ 0   $ 0
Nonvested, weighted average grant date fair value, beginning of period (in dollars per share) 2.92 $ 2.92 2.92
Granted, nonvested, weighted average grant date fair value (in dollars per share) 0   0
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Expired, Weighted Average Grant Date Fair 0   0
Nonvested options forfeited, weighted average grant date fair value (in dollars per share) 0   2.92
Nonvested, weighted average grant date fair value, end of period (in dollars per share) $ 2.92   $ 2.92
Stock Appreciation Rights (SARs) | Equity Option      
Number of Shares      
Number of nonvested shares, beginning of period (in shares) 1,720,623    
Granted, nonvested, number of shares (in shares) 0    
Vested, number of shares (in shares) (573,537)    
Nonvested options forfeited, number of shares (in shares) 0    
Number of nonvested shares, end of period (in shares) 1,147,086   1,720,623
Weighted Average Grant Date Fair Value      
Nonvested, weighted average grant date fair value, beginning of period (in dollars per share) $ 1.25    
Granted, nonvested, weighted average grant date fair value (in dollars per share) 0    
Vested, weighted average grant date fair value (in dollars per share) 1.25    
Nonvested options forfeited, weighted average grant date fair value (in dollars per share) 0    
Nonvested, weighted average grant date fair value, end of period (in dollars per share) $ 1.25   $ 1.25